SAN JOSE, Calif., Sept. 12, 2018 /PRNewswire/ -- Flex
(NASDAQ:FLEX), the Sketch-to-Scale® solutions provider that
designs and builds Intelligent Products for a Connected
World®, has assembled a clinical advisory board to leverage the
perspectives of leading doctors for the development of powerful
digital health solutions that integrate into and improve clinical
workflow to make a real-world impact on patient outcomes. Going
beyond consumer-grade digital health, Flex's Digital Health
business and the BrightInsight™ Clinical Board will be focused on
advancing medical-grade digital health solutions that effectively
integrate into providers' clinical workflow with the goal of
improving patient outcomes.
"As we continue to develop leading-edge digital health
solutions, it's paramount that we keep clinical workflow and the
clinician's point-of-view top of mind," said Kal Patel, M.D. and SVP of Digital Health at
Flex. "Although we are seeing a proliferation of effective digital
health solutions coming to market, they almost universally lack
integration into the health care professional's clinical workflow.
Without this integration, these solutions will not be able to
achieve scale and deliver upon their promise to make a clinical and
economic impact at the population level. We are honored to be
working with leading clinicians to help us tackle these
challenges."
The BrightInsight Clinical Board will advise Flex's Digital
Health business – from concept to commercialization – to ensure
advancements in three core areas: clinical workflow integration,
designing solutions that engage patients in self-care, and
facilitating the capture of clinically-relevant data and
analytics.
The members of the advisory board include:
Steven Edelman, M.D. – Dr.
Steven Edelman is a professor of
medicine in the Division of Endocrinology, Diabetes &
Metabolism at the University of California at
San Diego and the Veterans Affairs Healthcare System of
San Diego, and the director of the
Diabetes Care Clinic, VA Medical Center. Dr. Edelman is very
interested in patient advocacy and is the founder and director of
Taking Control of Your Diabetes, a not for profit organization with
the goal of educating, motivating and empowering those affected by
diabetes to take a more active role in their or their loved one's
condition.
Tania Elliott, M.D., FAAAAI,
FACAAI – Dr. Tania Elliott is on
faculty at NYU Langone Health and is a national spokesperson for
the American College of Allergy, Asthma, and Immunology. Dr.
Elliott is a nationally-recognized leader in telemedicine, serving
as first author for a position paper on telemedicine for Allergists
and having previously worked for Doctor on Demand where she saw
thousands of patients through real-time face-to-face video
consultations while recruiting and training top physicians around
the country. She previously served as the Chief Medical Officer of
the employer based healthcare company, EHE, where she focused on
patient engagement, preventive care and digital transformation.
Arturo Loaiza-Bonilla, M.D.,
MSEd, FACP – Dr. Arturo Loaiza-Bonilla is
the current Vice Chairman of the Department of Medical
Oncology at Cancer Treatment Centers of America, Chief of
Medical Oncology and Medical Director of Research at CTCA –
Philadelphia, and Co-Founder and
Chief Medical Officer at Massive Bio. Dr. Loaiza-Bonilla is a
dedicated practicing clinician and oncology expert with experience
at Abramson Cancer Center at the University of
Pennsylvania, University of Miami, Johns
Hopkins and the National Institutes of Health.
Steven Steinhubl, M.D. –
Dr. Steven Steinhubl is an Associate
Professor of Genomic Medicine at Scripps Research, a clinical
cardiologist and the Director of Digital Medicine at the Scripps
Research Translational Institute. As the head of the Digital
Medicine Division of STSI, he leads a research team in the design,
development and management of clinical programs built specifically
around the novel capabilities of digital technologies, including
wearable sensors and big data analytics.
Flex launched BrightInsight, its first digital health offering,
in March 2018. The announcement
marked an expansion of Flex's digital health capabilities through
the company's ability to offer an advanced, medical-grade managed
service platform that can capture and analyze regulated data from
connected medical devices, combination products or apps in a
secure, regulatory-compliant environment.
About Flex
Flex is the Sketch-to-Scale® solutions provider that designs
and builds Intelligent Products for a Connected World®. With
approximately 200,000 professionals across 30 countries, Flex
provides innovative design, engineering, manufacturing, real-time
supply chain insight and logistics services to companies of all
sizes in various industries and end-markets. For more information,
visit flex.com or follow us on Twitter @flexintl. Flex – Live
Smarter®
Investors & Analysts
Kevin Kessel
1 (408) 576-7985
kevin.kessel@flex.com
Media & Press
Paul Brunato
1 (408) 576-7534
paul.brunato@flex.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/flex-announces-brightinsight-clinical-board-to-advance-development-of-digital-solutions-for-pharma-and-medtech-300710966.html
SOURCE Flex